The Influence of Anti-C3aR and Anti-C5aR Antibody Levels on the Course of Specific Glomerulonephritis Types

Maciej Szymczak1, Harald Heidecke2, Marcelina Żabińska3

  • 1Clinical Department of Nephrology, Transplantation Medicine and Internal Diseases Wroclaw Medical University, 50-556 Wroclaw, Poland.

Journal of Clinical Medicine
|September 13, 2025
PubMed

Insights

Autoantibodies against complement receptors C3aR and C5aR are elevated in lupus nephritis patients. These antibody levels correlate with disease markers like albumin and total protein in lupus nephritis and FSGS.

Area of Science:

  • Immunology
  • Nephrology

Background:

  • The complement system's role in autoimmune diseases is established.
  • The impact of autoantibodies against complement receptors on glomerular diseases is not well understood.

Purpose of the Study:

  • To investigate the levels of anti-C3aR and anti-C5aR antibodies in various glomerular diseases.
  • To explore the correlation between these antibodies and clinical outcomes.

Main Methods:

  • Measured anti-C3aR and anti-C5aR antibody levels in patients with membranous nephropathy, FSGS, lupus nephritis, IgA nephropathy, mesangial proliferative glomerulonephritis, and ANCA vasculitis.
  • Compared antibody levels to a healthy control group.
  • Tracked clinical progress (creatinine, total protein, albumin) for up to two years and correlated with antibody levels.

Main Results:

  • Lupus nephritis patients exhibited significantly higher anti-C3aR and anti-C5aR antibody levels compared to other groups and healthy controls.
  • In lupus nephritis, anti-C3aR levels negatively correlated with albumin and total protein.
  • In FSGS, anti-C3aR levels positively correlated with albumin and total protein.

Conclusions:

  • Elevated anti-C3aR and anti-C5aR antibodies are characteristic of lupus nephritis.
  • These autoantibodies show differential correlations with key clinical markers (albumin, total protein) in lupus nephritis and FSGS, suggesting distinct pathogenic roles.